Michael Decker

15.6k total citations
313 papers, 12.3k citations indexed

About

Michael Decker is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Michael Decker has authored 313 papers receiving a total of 12.3k indexed citations (citations by other indexed papers that have themselves been cited), including 183 papers in Molecular Biology, 108 papers in Pharmacology and 105 papers in Cellular and Molecular Neuroscience. Recurrent topics in Michael Decker's work include Cholinesterase and Neurodegenerative Diseases (95 papers), Nicotinic Acetylcholine Receptors Study (86 papers) and Receptor Mechanisms and Signaling (85 papers). Michael Decker is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (95 papers), Nicotinic Acetylcholine Receptors Study (86 papers) and Receptor Mechanisms and Signaling (85 papers). Michael Decker collaborates with scholars based in United States, Germany and United Kingdom. Michael Decker's co-authors include James L. McGaugh, Jorge D. Brioni, Stephen P. Arnerić, Peter Curzon, Anthony W. Bannon, Jochen Lehmann, James P. Sullivan, Mark J. Majchrzak, Robert S. Bitner and David J.B. Kim and has published in prestigious journals such as Science, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Michael Decker

302 papers receiving 12.0k citations

Peers

Countries citing papers authored by Michael Decker

Since Specialization

Citations

This map shows the geographic impact of Michael Decker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Decker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Decker more than expected).

Fields of papers citing papers by Michael Decker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Decker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Decker. The network helps show where Michael Decker may publish in the future.

Co-authorship network of co-authors of Michael Decker

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Decker. A scholar is included among the top collaborators of Michael Decker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Decker. Michael Decker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Photoswitchable allosteric and dualsteric ligands in GPCR pharmacology 2025 ·Trends in Pharmacological Sciences ·Silvia Mori, (unknown), Michael Decker	0
2	Total Syntheses of the Amaryllidaceae Alkaloids Carltonines A–C and the Neuroprotective and Immunomodulatory Evaluation of Carltonine B 2025 ·Journal of Natural Products ·(unknown), Matthias Scheiner, (unknown), Gerhard Bringmann, Barbara Monti, Michael Decker	1
3	Design, Synthesis, and In Vitro Characterization of a Tryptamine-Based Visible-Light Photoswitchable 5-HT_2AR Ligand Showing Efficacy Preference for β-Arrestin over Mini-Gq 2025 ·Journal of Medicinal Chemistry ·(unknown), Eline Pottie, (unknown), Robert J. Tombari, Verena Weber, Paolo Carloni, Giulia Rossetti, David E. Olson, Christophe P. Stove, Michael Decker	0
4	Teaching Scientific Integrity in Academia: What and How Students Want to Learn? 2024 ·Journal of Academic Ethics ·(unknown), Michael Decker, (unknown), (unknown), (unknown), Dominik Groß	3
5	Correlating Predicted Reactivities with Experimental Inhibition Data of Covalent ChlaDUB1 Inhibitors 2024 ·ACS Medicinal Chemistry Letters ·(unknown), (unknown), Christoph Sotriffer, Michael Decker	1
6	Photo‐BQCA: Postiv allostere Modulatoren ermöglichen die optische Kontrolle des M₁‐Rezeptors 2024 ·Angewandte Chemie ·(unknown), (unknown), (unknown), (unknown), (unknown), Marcel Bermúdez, J. Robert Lane, Pau Gorostiza, Michael Decker	1
7	Photo‐BQCA: Positive Allosteric Modulators Enabling Optical Control of the M₁ Receptor 2024 ·Angewandte Chemie International Edition ·(unknown), (unknown), (unknown), (unknown), (unknown), Marcel Bermúdez, J. Robert Lane, Pau Gorostiza, Michael Decker	2
8	Dual-Acting Small Molecules: Subtype-Selective Cannabinoid Receptor 2 Agonist/Butyrylcholinesterase Inhibitor Hybrids Show Neuroprotection in an Alzheimer’s Disease Mouse Model 2023 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Julian Hofmann, Christophe P. Stove, Barbara Monti, Tangui Maurice, Michael Decker	17
9	Air quality observations onboard commercial and targeted Zeppelin flights in Germany – a platform for high-resolution trace-gas and aerosol measurements within the planetary boundary layer 2022 ·Atmospheric measurement techniques ·Ralf Tillmann, Georgios I. Gkatzelis, Franz Röhrer, Benjamin Winter, (unknown), (unknown), Anne Caroline Lange, (unknown), Elmar Friese, Michael Decker, Robert Wegener, (unknown), (unknown), Astrid Kiendler‐Scharr	2
10	Development of an Indole-Amide-Based Photoswitchable Cannabinoid Receptor Subtype 1 (CB₁R) “Cis-On” Agonist 2022 ·ACS Chemical Neuroscience ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Christoph Sotriffer, Christophe P. Stove, Kristina Lorenz, Martin J. Lohse, James N. Hislop, Michael Decker	14
11	Photoswitchable Pseudoirreversible Butyrylcholinesterase Inhibitors Allow Optical Control of Inhibition in Vitro and Enable Restoration of Cognition in an Alzheimer’s Disease Mouse Model upon Irradiation 2022 ·Journal of the American Chemical Society ·Matthias Scheiner, (unknown), Matthias Hoffmann, (unknown), (unknown), (unknown), Christoph Sotriffer, Tangui Maurice, Michael Decker	32
12	Enlightening the “Spirit Molecule”: Photomodulation of the 5‐HT_2A Receptor by a Light‐Controllable N,N‐Dimethyltryptamine Derivative 2022 ·Angewandte Chemie International Edition ·(unknown), Feng He, Eline Pottie, Christophe P. Stove, Michael Decker	17
13	Die Erhellung des “Bewusstseinsmoleküls”: Photomodulation des 5‐HT_2A Rezeptors durch ein licht‐steuerbares N,N‐Dimethyltryptamin‐Derivat 2022 ·Angewandte Chemie ·(unknown), Feng He, Eline Pottie, Christophe P. Stove, Michael Decker	1
14	Selective Pseudo-irreversible Butyrylcholinesterase Inhibitors Transferring Antioxidant Moieties to the Enzyme Show Pronounced Neuroprotective Efficacy In Vitro and In Vivo in an Alzheimer’s Disease Mouse Model 2021 ·Journal of Medicinal Chemistry ·Matthias Scheiner, Matthias Hoffmann, Feng He, (unknown), Arnaud Chatonnet, Barbara Monti, Tangui Maurice, Michael Decker	38
15	The Structure of Cyclodecatriene Collinolactone, its Biosynthesis, and Semisynthetic Analogues: Effects of Monoastral Phenotype and Protection from Intracellular Oxidative Stress 2021 ·Angewandte Chemie International Edition ·(unknown), (unknown), Matthias Scheiner, (unknown), (unknown), (unknown), (unknown), (unknown), Axel Zeeck, Tilmann Weber, Isabel Usón, Ralf Kemkemer, Michael Decker, Stephanie Grond	7
16	Investigation of Inactive-State κ Opioid Receptor Homodimerization via Single-Molecule Microscopy Using New Antagonistic Fluorescent Probes 2020 ·Journal of Medicinal Chemistry ·(unknown), Zsombor Kőszegi, Yann Lanoiselée, Harald Hübner, Peter Gmeiner, Davide Calebiro, Michael Decker	16
17	Dual-Acting Cholinesterase–Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo 2019 ·Journal of Medicinal Chemistry ·Matthias Scheiner, (unknown), Sandra Gunesch, Matthias Hoffmann, Massimo Nabissi, Oliviero Marinelli, Marina Naldi, Manuela Bartolini, Sabrina Petralla, (unknown), Barbara Monti, Christina Falkeis, Michael Vieth, Harald Hübner, Peter Gmeiner, Rangan Maitra, Tangui Maurice, Michael Decker	39
18	Physiologic Effects of Rhythmical Massage: A Prospective Exploratory Cohort Study 2013 ·The Journal of Alternative and Complementary Medicine ·(unknown), (unknown), Daniel Krüerke, (unknown), B. Schnorr, Lukas Rist, (unknown), Michael Decker, Ana Paula Simões‐Wüst	29
19	Surveillance of colonization and infection with Staphylococcus aureus susceptible or resistant to methicillin in a community skilled-nursing facility 1997 ·Data Archiving and Networked Services (DANS) ·(unknown), Thomas C. Cesario, (unknown), (unknown), (unknown), Michael Decker, Lauri Thrupp	2
20	Pharmacological treatment of Alzheimer's disease : molecular and neurobiological foundations 1997 ·Jorge D. Brioni, Michael Decker	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact